Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check3 days agoChange DetectedFooter now shows Revision: v3.3.4 (replacing v3.3.3); core study content and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedUpdated the study page to revision v3.3.3 with a reorganized Locations section listing new site locations (Arkansas, California, North Carolina, Pennsylvania, Utah). The HHS Vulnerability Disclosure link was removed.SummaryDifference0.6%

- Check53 days agoChange DetectedPublications section updated to indicate that publications are automatically filled from PubMed and may not be about the study, and to reflect revision v3.3.2; the previous wording described PubMed-origin publications and referenced revision v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved a general government funding/operating status notice from the page. The study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.4%

- Check75 days agoChange DetectedThe new screenshot preserves the same study details and sections as the previous version; there are no core content additions or deletions detected, and any differences are limited to layout or styling.SummaryDifference0.4%

- Check103 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference5%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.